OBJECTIVE: To demonstrate the sensitivity of a recently developed whole-brain magnetic resonance spectroscopic imaging (MRSI) sequence to cerebral pathology and disability in amyotrophic lateral sclerosis (ALS), and compare with measures derived from diffusion tensor imaging. METHODS: Whole-brain MRSI and diffusion tensor imaging were undertaken in 13 patients and 14 age-similar healthy controls. Mean N-acetylaspartate (NAA), fractional anisotropy, and mean diffusivity were extracted from the corticospinal tract, compared between groups, and then in relation to disability in the patient group. RESULTS: Significant reductions in NAA were found along the course of the corticospinal tracts on whole-brain MRSI. There were also significant changes in fractional anisotropy (decreased) and mean diffusivity (increased) in the patient group, but only NAA showed a significant relationship with disability (r = 0.65, p = 0.01). CONCLUSION: Whole-brain MRSI has potential as a quantifiable neuroimaging marker of disability in ALS. It offers renewed hope for a neuroimaging outcome measure with the potential for harmonization across multiple sites in the context of a therapeutic trial.
OBJECTIVE: To demonstrate the sensitivity of a recently developed whole-brain magnetic resonance spectroscopic imaging (MRSI) sequence to cerebral pathology and disability in amyotrophic lateral sclerosis (ALS), and compare with measures derived from diffusion tensor imaging. METHODS: Whole-brain MRSI and diffusion tensor imaging were undertaken in 13 patients and 14 age-similar healthy controls. Mean N-acetylaspartate (NAA), fractional anisotropy, and mean diffusivity were extracted from the corticospinal tract, compared between groups, and then in relation to disability in the patient group. RESULTS: Significant reductions in NAA were found along the course of the corticospinal tracts on whole-brain MRSI. There were also significant changes in fractional anisotropy (decreased) and mean diffusivity (increased) in the patient group, but only NAA showed a significant relationship with disability (r = 0.65, p = 0.01). CONCLUSION: Whole-brain MRSI has potential as a quantifiable neuroimaging marker of disability in ALS. It offers renewed hope for a neuroimaging outcome measure with the potential for harmonization across multiple sites in the context of a therapeutic trial.
Authors: C M Ellis; A Simmons; D K Jones; J Bland; J M Dawson; M A Horsfield; S C Williams; P N Leigh Journal: Neurology Date: 1999-09-22 Impact factor: 9.910
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Sumei Wang; Harish Poptani; John H Woo; Lisa M Desiderio; Lauren B Elman; Leo F McCluskey; Jaroslaw Krejza; Elias R Melhem Journal: Radiology Date: 2006-04-26 Impact factor: 11.105
Authors: Camilla R V Blain; Victoria C Williams; Clare Johnston; Biba R Stanton; Jeban Ganesalingam; Jozef M Jarosz; Derek K Jones; Gareth J Barker; Steve C R Williams; Nigel P Leigh; Andy Simmons Journal: Amyotroph Lateral Scler Date: 2007-10-08
Authors: Varan Govind; Khema R Sharma; Andrew A Maudsley; Kristopher L Arheart; Gaurav Saigal; Sulaiman Sheriff Journal: PLoS One Date: 2012-04-23 Impact factor: 3.240
Authors: Mohammad Sabati; Sulaiman Sheriff; Meng Gu; Juan Wei; Henry Zhu; Peter B Barker; Daniel M Spielman; Jeffry R Alger; Andrew A Maudsley Journal: Magn Reson Med Date: 2014-10-29 Impact factor: 4.668
Authors: Martin Wilson; Ovidiu Andronesi; Peter B Barker; Robert Bartha; Alberto Bizzi; Patrick J Bolan; Kevin M Brindle; In-Young Choi; Cristina Cudalbu; Ulrike Dydak; Uzay E Emir; Ramon G Gonzalez; Stephan Gruber; Rolf Gruetter; Rakesh K Gupta; Arend Heerschap; Anke Henning; Hoby P Hetherington; Petra S Huppi; Ralph E Hurd; Kejal Kantarci; Risto A Kauppinen; Dennis W J Klomp; Roland Kreis; Marijn J Kruiskamp; Martin O Leach; Alexander P Lin; Peter R Luijten; Małgorzata Marjańska; Andrew A Maudsley; Dieter J Meyerhoff; Carolyn E Mountford; Paul G Mullins; James B Murdoch; Sarah J Nelson; Ralph Noeske; Gülin Öz; Julie W Pan; Andrew C Peet; Harish Poptani; Stefan Posse; Eva-Maria Ratai; Nouha Salibi; Tom W J Scheenen; Ian C P Smith; Brian J Soher; Ivan Tkáč; Daniel B Vigneron; Franklyn A Howe Journal: Magn Reson Med Date: 2019-03-28 Impact factor: 4.668